Zobrazeno 1 - 9
of 9
pro vyhledávání: '"William Petros"'
Autor:
Carl Shultz, Christopher Gates, William Petros, Kelly Ross, Laruen Veltri, Michael Craig, Sijin Wen, Donald A. Primerano, Lori Hazlehurst, James Denvir, Konstantinos Sdrimas
Publikováno v:
Cancer Reports, Vol 6, Iss 3, Pp n/a-n/a (2023)
Abstract Background Previous population health studies examining adults with acute myeloid leukemia (AML); however many of these, such as the Cancer Genome Atlas, are derived from databases collected by large urban centers. Due to its unique industry
Externí odkaz:
https://doaj.org/article/81dd1662f5204386afe967a553638602
Autor:
Carl Shultz, Christopher Gates, William Petros, Kelly Ross, Laruen Veltri, Michael Craig, Sijin Wen, Donald A. Primerano, Lori Hazlehurst, James Denvir, Konstantinos Sdrimas
Publikováno v:
Cancer reports (Hoboken, N.J.)REFERENCES.
Previous population health studies examining adults with acute myeloid leukemia (AML); however many of these, such as the Cancer Genome Atlas, are derived from databases collected by large urban centers. Due to its unique industry and environmental e
Autor:
Michael Sweet, Michael Craig, Aaron Cumpston, Douglas Slain, Sijin Wen, R. Brigg Turner, William Petros, Frank Briggs, Mehdi Hamadani
Publikováno v:
Antimicrobial Agents and Chemotherapy. 60:1830-1833
The current recommendations for intravenous (i.v.) acyclovir dosing in obese patients suggest using ideal body weight (IBW) rather than total body weight (TBW). To our knowledge, no pharmacokinetic analysis has validated this recommendation. This sin
Publikováno v:
Pharmacy and Pharmacology Communications. 5:399-402
Granulocyte colony-stimulating factor (G-CSF) at 250 μg kg−1 per day stimulates white blood cell (WBC) proliferation in mice with significant increases from 72–120 h. Lipopolysaccharide (LPS) treatment as a single dose (5 mg kg−1) at 72 h abol
Autor:
Gregory B. Lesinski, William E. Carson, Carl H. June, Natarajan Muthusamy, William Petros, Thomas Olencki, Wei Zen Wei, Michael T. Lotze, Pawel Kalinski, Elizabeth A. Repasky
The Translational Research Cancer Centers Consortium (TrC3) is a cancer immunotherapy network, established to promote biologic therapeutics in the Midwestern and Northeastern regions of The United States. The 13th Annual Meeting of the TrC3 was hoste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83683caefd8477c25f9b902248efa41b
https://europepmc.org/articles/PMC3793645/
https://europepmc.org/articles/PMC3793645/
Autor:
John L. Marshall, Waun Ki Hong, William Petros, Naiyer A. Rizvi, Michael J. Hawkins, Jonathan M. Kurie, Elizabeth Ness, Helena Jacobs, Wayne D. Brenckman, Craig Kessler, Jin S. Lee
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(16)
PURPOSE: The goals of this study were to determine the safety, toxicity, and pharmacokinetics of TAC-101, a novel synthetic retinoic acid receptor-alpha (RAR-α) selective retinoid, in patients with advanced cancer. PATIENTS AND METHODS: Twenty-nine
Autor:
Yvonne A Efebera, Parvathi Ranganathan, Xueyan Yu, Jessica Hofstetter, Sabrina L Garman, Laura Gibson, William Petros, Michael Craig, Cecelia Fernandez-Cymering, Mehdi Hamadani, Guido Marcucci, Steven M. Devine, Muller Fabbri, Ramiro Garzon
Publikováno v:
Blood. 122:4471-4471
Background aGVHD is one of the most frequent and lethal complications after allo HSCT, underscoring the need to develop novel therapies. To achieve this goal, aGVHD mechanisms needs to be further elucidated. Recently it was reported that miRNAs are m
Autor:
Merrill Egorin, Ramesh K. Ramanathan, Joseph Gibbons, William Petros, S. Percy Ivy, Scot C. Remick
Publikováno v:
Journal of Clinical Oncology. 26:4227-4228
Publikováno v:
Ophthalmology. 104:170-171